ESMO Guidance for Reporting Oncology real-World evidence (GROW).
Loading...
Embargo End Date
ICR Authors
Authors
Castelo-Branco, L
Pellat, A
Martins-Branco, D
Valachis, A
Derksen, JWG
Suijkerbuijk, KPM
Dafni, U
Dellaporta, T
Vogel, A
Prelaj, A
Groenwold, RHH
Martins, H
Stahel, R
Bliss, J
Kather, J
Ribelles, N
Perrone, F
Hall, PS
Dienstmann, R
Booth, CM
Pentheroudakis, G
Delaloge, S
Koopman, M
Pellat, A
Martins-Branco, D
Valachis, A
Derksen, JWG
Suijkerbuijk, KPM
Dafni, U
Dellaporta, T
Vogel, A
Prelaj, A
Groenwold, RHH
Martins, H
Stahel, R
Bliss, J
Kather, J
Ribelles, N
Perrone, F
Hall, PS
Dienstmann, R
Booth, CM
Pentheroudakis, G
Delaloge, S
Koopman, M
Document Type
Journal Article
Date
2023-11-01
Date Accepted
2023-11-01
Abstract
•Real-world evidence in oncology is evolving rapidly with many particularities.•This guidance provides key recommendations for reporting real-world evidence studies in oncology.•Recommendations are based on a review of current evidence and the authors' collective expert opinion.•Authors are a multidisciplinary group of experts from different institutions and countries.•Guidance is provided for full article development, including title, introduction, methods, results, discussion, conclusion.
Citation
ESMO REAL WORLD DATA AND DIGITAL ONCOLOGY, 2023, 1
Source Title
ESMO REAL WORLD DATA AND DIGITAL ONCOLOGY
Publisher
ELSEVIER
ISSN
2949-8201
eISSN
2949-8201
Collections
Research Team
Clin Trials & Stats Unit